We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers ... Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS and Covid-19 and collaboration projects in the cancer immunotherapy field. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0 | CS |
52 | -0.009 | -90 | 0.01 | 0.01 | 0.001 | 57 | 0.00670075 | CS |
156 | -54.399 | -99.9981617647 | 54.4 | 230 | 0.001 | 300381 | 23.61167832 | CS |
260 | -69.999 | -99.9985714286 | 70 | 380 | 0.001 | 222675 | 73.3889549 | CS |
Symbol | Price | Vol. |
---|---|---|
GRLFGreen Leaf Innovations Inc (PK) | $ 0.0001 (0.00%) | 153.91M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | $ 0.0033 (0.00%) | 83.97M |
GTVHGolden Triangle Ventures Inc (PK) | $ 0.0003 (-25.00%) | 80.68M |
PHILPHI Group Inc (PK) | $ 0.0002 (0.00%) | 71.64M |
SPQSSportsQuest Inc (PK) | $ 0.0004 (-20.00%) | 61.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions